Glenmark to study potential COVID-19 drug combination; to look to enroll 158 hospitalised patients

On 1 May, Glenmark Pharmaceuticals said it has become the first company in India to receive approval from Drug Controller General of India (DCGI) to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients.


The post Glenmark to study potential COVID-19 drug combination; to look to enroll 158 hospitalised patients appeared first on Firstpost.

Comments

Post a Comment

Popular posts from this blog

India’s first quarter GDP growth likely to be weakest since 2012; coronavirus, lockdown halted economic activity: Poll

Forecasts for gross domestic product (GDP) data, due to be released on 29 May, ranged between +4.5 percent and -1.5 percent, underscoring the widespread uncertainty on the impact of the coronavirus on the economy at that stage. The post India’s first quarter GDP growth likely to be weakest since 2012; coronavirus, lockdown halted economic activity: Poll appeared first on Firstpost.
Read more